An Integrating Immune-Related Signature to Improve Prognosis of Hepatocellular Carcinoma
Growing evidence suggests that the superiority of long noncoding RNAs (lncRNAs) and messenger RNAs (mRNAs) could act as biomarkers for cancer prognosis. However, the prognostic marker for hepatocellular carcinoma with high accuracy and sensitivity is still lacking. In this research, a retrospective,...
Main Authors: | Rui Zhu, Wenna Guo, Xin-Jian Xu, Liucun Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Computational and Mathematical Methods in Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/8872329 |
Similar Items
-
An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
by: Rui Zhu, et al.
Published: (2019-10-01) -
A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma
by: Yueping Zhan, et al.
Published: (2015-01-01) -
Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma
by: Xuanlong Du, et al.
Published: (2020-12-01) -
Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma
by: Hu B, et al.
Published: (2020-11-01) -
Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
by: Yuan Yang, et al.
Published: (2021-06-01)